1. Home
  2. NOTV vs OCCI Comparison

NOTV vs OCCI Comparison

Compare NOTV & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • OCCI
  • Stock Information
  • Founded
  • NOTV 1974
  • OCCI N/A
  • Country
  • NOTV United States
  • OCCI United States
  • Employees
  • NOTV N/A
  • OCCI N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • OCCI Trusts Except Educational Religious and Charitable
  • Sector
  • NOTV Health Care
  • OCCI Finance
  • Exchange
  • NOTV Nasdaq
  • OCCI Nasdaq
  • Market Cap
  • NOTV 137.5M
  • OCCI 146.8M
  • IPO Year
  • NOTV 1997
  • OCCI N/A
  • Fundamental
  • Price
  • NOTV $1.96
  • OCCI $6.69
  • Analyst Decision
  • NOTV Strong Buy
  • OCCI
  • Analyst Count
  • NOTV 3
  • OCCI 0
  • Target Price
  • NOTV $6.25
  • OCCI N/A
  • AVG Volume (30 Days)
  • NOTV 840.6K
  • OCCI 115.8K
  • Earning Date
  • NOTV 05-07-2025
  • OCCI 12-11-2023
  • Dividend Yield
  • NOTV N/A
  • OCCI 24.32%
  • EPS Growth
  • NOTV N/A
  • OCCI N/A
  • EPS
  • NOTV N/A
  • OCCI N/A
  • Revenue
  • NOTV $480,402,000.00
  • OCCI N/A
  • Revenue This Year
  • NOTV $5.84
  • OCCI N/A
  • Revenue Next Year
  • NOTV $5.74
  • OCCI $10.19
  • P/E Ratio
  • NOTV N/A
  • OCCI N/A
  • Revenue Growth
  • NOTV N/A
  • OCCI N/A
  • 52 Week Low
  • NOTV $1.15
  • OCCI $5.47
  • 52 Week High
  • NOTV $6.48
  • OCCI $10.15
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 47.15
  • OCCI 54.48
  • Support Level
  • NOTV $1.75
  • OCCI $6.49
  • Resistance Level
  • NOTV $2.36
  • OCCI $6.79
  • Average True Range (ATR)
  • NOTV 0.18
  • OCCI 0.11
  • MACD
  • NOTV 0.07
  • OCCI 0.02
  • Stochastic Oscillator
  • NOTV 45.95
  • OCCI 79.59

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About OCCI OFS Credit Company Inc.

OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.

Share on Social Networks: